Nivolumab 40 Mg Injection

Product Description

Nivolumab 40 Mg Injection is a medication that belongs to a class of drugs known as immune checkpoint inhibitors. Thos is indicated for the treatment of various types of cancer, including melanoma, non-small cell lung cancer, renal cell carcinoma, classical Hodgkin lymphoma, squamous cell carcinoma of the head and neck, urothelial carcinoma, colorectal cancer, hepatocellular carcinoma, and certain types of gastric cancer, esophageal cancer, and cervical cancer. It works by targeting and blocking a protein called programmed cell death protein 1 (PD-1) on certain immune cells called T cells. Nivolumab 40 Mg Injection is effective in the treatment of several types of cancer, often providing durable responses and prolonged survival in some patients.

Specification